As of 2025-07-10, the EV/EBITDA ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is -2.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASP.TO's latest enterprise value is 61.42 mil CAD. ASP.TO's TTM EBITDA according to its financial statements is -25.78 mil CAD. Dividing these 2 quantities gives us the above ASP.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 4.5x | 4.3x |
| Forward P/E multiples | 3.4x - 5.2x | 4.3x |
| Fair Price | (23.26) - (28.09) | (27.18) |
| Upside | -6561.7% - -7901.5% | -7648.7% |
| Date | EV/EBITDA |